Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies.
about
Comparison of once-daily versus twice-daily combination of ropinirole prolonged release in Parkinson's disease.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs.
P2860
Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long half-life and prolonged-r ...... ole prolonged-release studies.
@en
Long half-life and prolonged-r ...... ole prolonged-release studies.
@nl
type
label
Long half-life and prolonged-r ...... ole prolonged-release studies.
@en
Long half-life and prolonged-r ...... ole prolonged-release studies.
@nl
prefLabel
Long half-life and prolonged-r ...... ole prolonged-release studies.
@en
Long half-life and prolonged-r ...... ole prolonged-release studies.
@nl
P2093
P50
P1476
Long half-life and prolonged-r ...... role prolonged-release studies
@en
P2093
F Anzellotti
F Ciccocioppo
M V De Angelis
P304
P356
10.1016/S1353-8020(09)70842-9
P478
15 Suppl 4
P577
2009-12-01T00:00:00Z